As a leading contract research organization (CRO) for human abuse potential (HAP) trials, Dr. Vince Clinical Research has expertise in the creation and implementation of positive control groups. By following well-defined protocols, DVCR produces optimized results for clients throughout the drug development process, a critical focus for conducting HAP trials.
This video is part 6 of our Human Abuse Potential Study Series. Join Naama Levy-Cooperman, Director at Altreos Research Partners, as she discusses positive control requirements, selection processes and dose determination. Stay tuned for additional videos in which we continue to showcase what makes DVCR experts in human abuse potential studies.
